Spyke

Syndicated from the fediverse. Read and engage on the original instance.

View original on lemm.ee
neurodegdissupport·Neurodegenative Disease Supportby108beads

Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients

Racial disparities in drug trials, and disparities in overall medical care, among other factors, make the recently-approved Alzheimer's break-through drug lecanemab less likely to benefit African Americans.

Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patientshttps://kffhealthnews.org/news/article/fda-alzheimers-drug-approval-process-lecanemab-leqembi-racial-disparities/Open linkView original on lemm.ee
1
Comments1

1 reply

You reached the end

Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients | Spyke